| Ropeginterferon Alfa-2b studied in …STUDIED_INderived17 of 17show fewer |
|---|
| → studied in | NCT07722611Phase 2/Phase 3 · recruiting A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025) · 17 trials list this drug (11 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07269470Phase 2 · recruiting Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase · 17 trials list this drug (11 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06468033Phase 3 · active not recruiting P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk · 17 trials list this drug (11 active) | — | — | Myeloproliferative Neoplasm,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06290765Phase 4 · withdrawn Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera · 17 trials list this drug (11 active) | — | — | Myeloproliferative Neoplasm,Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04285086Phase 3 · active not recruiting Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance · 17 trials list this drug (11 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06506084recruiting Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV) · 17 trials list this drug (11 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07468916Phase 2 · not yet recruiting Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia · 17 trials list this drug (11 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm,Atypical Chronic Myeloid Leukemia,Chronic Myelomonocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07047885Phase 1 · recruiting Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL) · 17 trials list this drug (11 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04182100Phase 2 · completed Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply · 17 trials list this drug (11 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05481151Phase 3 · active not recruiting A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV · 17 trials list this drug (11 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482971Phase 2 · active not recruiting A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET · 17 trials list this drug (11 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05485948Phase 2 · active not recruiting A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU · 17 trials list this drug (11 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04655092Phase 3 · recruiting Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients · 17 trials list this drug (11 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06002490Phase 3 · completed A Study to Evaluate P1101 in Japanese PV Patients · 17 trials list this drug (11 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03003325Phase 2 · completed The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV · 17 trials list this drug (11 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04233840Phase 1/Phase 2 · unknown P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma · 17 trials list this drug (11 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01933906Phase 1 · completed Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response · 17 trials list this drug (11 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |